JHS Svendgaard Laboratories Limited — Results, 12-02-2025: Integrated Filing- Financial

JHS Svendgaard Laboratories Limited has released its financial results for the quarter and nine months ended December 31, 2024. Revenue from operations reached ₹22,659.5 lakhs, while net loss for the period was ₹1,831.86 lakhs, reflecting continued challenges in profitability. The company also reported a revision of its Deferred Tax Asset by approximately ₹9.5 crore due to non-adjustable carried forward losses. The management remains confident regarding the recovery of capital advances amounting to approximately ₹3,011.15 lakhs, which are intended for new projects in Jammu and Kashmir. This update may impact investor sentiment given the ongoing losses and the company’s efforts to enhance operational efficiencies while navigating expansion plans. The outlook remains cautious with potential benefits from project developments in the future.